The S447X variant of lipoprotein lipase gene is associated with metabolic syndrome and lipid levels among Turks

Clinica Chimica Acta

Volumn 383, Issue 1-2, 2007, Pages 110-115

  Komurcu Bayrak, Evrim ^a   Onat, Altan ^a   Poda, Mehves ^a   Humphries, Steve E ^b   Acharya, Jayshree ^b   Hergenc, Gülay ^c   Coban, Neslihan ^a   Can, Gunay ^a   Erginel Unaltuna, Nihan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c YILDIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Lipids; Lipoprotein lipase; Metabolic syndrome; S447X variant; Turkish population

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TURKEY (REPUBLIC);

AGED; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIPIDS; LIPOPROTEIN LIPASE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; SEX FACTORS; TURKEY;

EID: 34347353158     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.05.007     Document Type: Article

References (30)

1. Zechner R. The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism. Curr Opin Lipidol 8 (1997) 77-88
2. Van Eck M., Zimmermann R., Groot P.H., Zechner R., and Van Berkel T.J. Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 20 (2000) E53-E62
3. Goodarzi M.O., Guo X., Taylor K.D., et al. Lipoprotein lipase is a gene for insulin resistance in Mexican Americans. Diabetes 53 (2004) 214-220
4. Jemaa R., Tuzet S., Portos C., Betoulle D., Apfelbaum M., and Fumeron F. Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes Relat Metab Disord 19 (1995) 270-274
5. Holmer S.R., Hengstenberg C., Mayer B., et al. Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population. Cardiovasc Res 47 (2000) 806-812
6. Jemaa R., Fumeron F., Poirier O., et al. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res 36 (1995) 2141-2146
7. Fisher R.M., Humphries S.E., and Talmud P.J. Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis 135 (1997) 145-159
8. Murthy V., Julien P., and Gagne C. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther 70 (1996) 101-105
9. Hata A., Robertson M., Emi M., and Lalouel J.M. Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res 18 (1990) 5407-5411
10. Wittrup H.H., Tybjaerg-Hansen A., and Nordestgaard B.G. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 99 (1999) 2901-2907
11. Humphries S.E., Nicaud V., Margalef J., Tiret L., and Talmud P.J. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 18 (1998) 526-534
12. Henderson H.E., Kastelein J.J., Zwinderman A.H., et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J Lipid Res 40 (1999) 735-743
13. Gagné S.E., Larson M.G., Pimstone S.N., et al. A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study. Clin Genet 55 (1999) 450-454
14. Groenemeijer B.E., Hallman M.D., Reymer P.W.A., et al. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Circulation 95 (1997) 2628-2635
15. Nierman M.C., Rip J., Kuivenhoven J.A., et al. Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance. Metabolism 54 (2005) 1499-1503
16. Garenc C., Pérusse L., Gagnon J., et al. Linkage and association studies of the lipoprotein lipase gene with postheparin plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations: the HERITAGE Family Study. Metabolism 49 (2000) 432-439
17. Zhang H., Henderson H., Gagne S.E., et al. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta 1302 (1996) 159-166
18. Corella D., Guillen M., Saiz C., et al. Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus. J Lipid Res 43 (2002) 416-427
19. Lee J., Tan C.S., Chia K.S., et al. The lipoprotein lipase S447X polymorphism and plasma lipids: interactions with APOE polymorphisms, smoking, and alcohol consumption. J Lipid Res 45 (2004) 1132-1139
20. Onat A., Ceyhan K., Başar Ö., Erer B., Toprak S., and Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 165 (2002) 285-292
21. Mahley R.W., Pepin J., Palaoglu K.E., Malloy M.J., Kane J.P., and Bersot T.P. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype. J lipid Res 41 (2000) 1290-1291
22. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 156 (2001) 1-10
23. Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III]. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP]. JAMA 285 (2001) 2486-2497
24. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
25. Onat A., Hergenc G., Turkmen S., Yazici M., Sari I., and Can G. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism 55 (2006) 445-452
26. Onat A., Uyarel H., Hergenc G., Karabulut A., Albayrak S., and Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 191 (2007) 182-190
27. Wittrup H.H., Nordestgaard B.G., Steffensen R., Jensen G., and Tybjaerg-Hansen A. Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study. Atherosclerosis 165 (2002) 119-126
28. Razzaghi H., Aston C.E., Hamman R.F., and Kamboh M.I. Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels. Hum Genet 107 (2000) 257-267
29. Kobayashi J., Saito K., Fukamachi I., et al. Pre-heparin plasma lipoprotein lipase mass: correlation with intra-abdominal visceral fat accumulation. Horm Metab Res 33 (2001) 412-416
30. Talmud P.J., Hawe E., Robertson K., Miller G.J., Miller N.E., and Humphries S.E. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men. Ann Hum Genet 66 (2002) 111-124